NxStage Medical

What NxStage Medical does

NxStage Medical, Inc. is a US medical device company that develops, manufactures, and markets home hemodialysis systems and connected health software for the treatment of end-stage renal disease (ESRD). Founded in 1997 and headquartered in Lawrence, Massachusetts, the company built its position on the NxStage System One portable hemodialysis machine and later extended to the VersiHD platform with GuideMe Software (launched April 2024), featuring touchscreen-guided instructions and remote clinician monitoring. NxStage's flagship regulatory milestone is the 2017 FDA clearance making its systems the first and only hemodialysis machines approved in the US for solo/independent home hemodialysis without a care partner during waking hours, plus support for nocturnal home hemodialysis and peritoneal dialysis modalities.

The company operates a hardware-plus-consumables model (dialysis machines, dialyzers, blood purification disposables) complemented by a recurring-software stack: the Nx2me Connected Health platform, Nx2me Clinician Portal, NxRx online prescription and ordering system, NxDocuments training library, and a Dosing Calculator. Equipment is prescribed by nephrologists and dispensed primarily through Fresenius Medical Care's home therapies distribution channel, including certified home training programs and direct patient fulfillment; reimbursement flows predominantly through Medicare's ESRD benefit, Medicaid, and private insurance. Marketing emphasizes patient quality-of-life benefits — travel flexibility, independence, and nocturnal scheduling — supported by patient testimonials, the 'Visits with Vanessa' podcast, webinars, and a Patient Consultant program.

Following its March 2025 acquisition by NIPRO Corporation (a Japanese medical device company), NxStage operates as a wholly-owned subsidiary within NIPRO's renal care portfolio. Prior to the acquisition, NxStage was publicly traded on NASDAQ under ticker NXTM. The company serves three primary personas: ESRD patients performing home dialysis, nephrologists and dialysis clinicians managing prescriptions and remote monitoring, and care partners supporting home treatment. Its geographic footprint is concentrated in the United States with selected EMEA (UK) activity, with international expansion now channeled through NIPRO's global distribution infrastructure.

Name

NxStage Medical

Legal name

NxStage Medical, Inc.

Website

http://www.nxstage.com

Company type

Private

Founded year

1998

Operating status

Acquired

Headcount range

5,001–10,000 employees

Short description

NxStage Medical develops home hemodialysis systems and connected health software for end-stage renal disease (ESRD) patients, including the VersiHD and System One platforms. Acquired by NIPRO in March 2025, the company distributes products through Fresenius Medical Care's home therapies channel.

Ownership category

akta.pro rank

Product category

Home Hemodialysis Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hemodialysis Machines & Systems (HLAHAKAA)

akta.pro secondary industries

Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Home Dialysis Programs (Home HD/PD Training & Support) (HLAKAHAK)

Keywords

• Home hemodialysis systems
• Renal care medical devices
• Portable dialysis equipment
• Peritoneal dialysis products
• Kidney disease treatment devices

Headquarters

HQ city

Lawrence

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Dialysis Equipment and Consumables Sales: Sale of home hemodialysis machines (NxStage VersiHD, System One) and associated consumables including dialyzers and blood purification equipment to dialysis centers and directly to patients via prescription.
2. Software and Digital Health Services: Online prescription platforms (NxRx), clinician portals (Nx2me), and dosing calculator tools that support home dialysis treatment management and patient monitoring.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

NxStage Medical develops, manufactures, and markets portable hemodialysis machines (NxStage VersiHD with GuideMe Software and System One) and associated consumables for the treatment of end-stage renal disease (ESRD) in the home setting. The company also provides connected health software (Nx2me), online prescription systems (NxRx), and clinical decision-support tools (Dosing Calculator, NxDocuments) used by nephrologists and dialysis clinicians to prescribe, monitor, and support home hemodialysis and peritoneal dialysis therapy.

Product overview

NxStage Medical, now part of NIPRO's renal product portfolio following March 2025 acquisition, offers a comprehensive ecosystem of home dialysis products and connected health solutions. The core product line centers on the NxStage Versi HD system (with and without GuideMe Software) and the System One portable hemodialysis machine, all designed for home use. Supporting these devices is a suite of software and portal tools including Nx2me Connected Health for remote monitoring, the Nx2me Clinician Portal for clinical data access, NxRx for prescription management, NxDocuments for training resources, and a Dosing Calculator for prescription assistance. Treatment modalities span both hemodialysis (HHD) and peritoneal dialysis (PD), with options for standard, solo/independent, and nocturnal home treatment approaches.

Differentiator

Problem solved

Functional benefit

Brands

• NxStage VersiHD: Advanced home dialysis system with GuideMe Software featuring touchscreen-guided instructions and remote clinician monitoring capabilities.
• System One
• Nx2me
• NxRx
• NxDocuments
• PureFlow

Products and services

• NxStage VersiHD with GuideMe Software Advanced home hemodialysis system with touchscreen-guided instructions and remote clinician monitoring capabilities, designed for patients performing hemodialysis treatments at home.
• NxStage VersiHD Home hemodialysis system designed for patients to perform hemodialysis treatments in the comfort of their home with flexibility in scheduling.
• System One Portable Hemodialysis Machine Portable hemodialysis machine enabling patients to perform dialysis treatments at home or while traveling, designed for portability and ease of use.
• Solo/Independent Home Hemodialysis (HHD) Treatment Modality Innovative home hemodialysis therapy option performed without a care partner during waking hours, supported by NxStage system clearance, offering greater independence and flexible scheduling.
• Nocturnal Home Hemodialysis (HHD) Treatment Modality Dialysis therapy performed overnight while the patient and care partner sleep, with longer and slower treatments that more closely resemble natural kidney function.
• Peritoneal Dialysis (PD) Treatment Modality Dialysis treatment using the peritoneal membrane inside the abdomen as a filter, including Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) modalities performed daily at home.

Quantifiable outcome

• NxStage systems enable patients to travel and maintain active lifestyles while continuing home hemodialysis treatments
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• InterWell HealthcoreStrategic or Co-development Partner · 1 August 2025Fresenius Medical Care acquired InterWell Health, a physician organization, in August 2025 to drive innovation in kidney care. This partnership/ownership connects Fresenius's dialysis operations with physician-led care delivery for integrated kidney disease management.
• NIPROcoreOthers · 1 March 2025NIPRO acquired NxStage Medical in March 2025 to expand its renal product portfolio, making NxStage a subsidiary of NIPRO Corporation. This acquisition integrates NxStage's home dialysis technology into NIPRO's existing renal care business.
• Baxter International Inc.minorOthers · 1 August 2024Baxter International acquired The Carlyle Group for $3.8 billion in August 2024 as a strategic move to expand Baxter's renal care portfolio amid growing demand for dialysis products and services. This represents competitive positioning rather than direct partnership with NxStage.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Outset Medical: Outset Medical's Tablo system is a direct competitor in home and in-center hemodialysis with similar portability and ease-of-use positioning, targeting the same ESRD patient and clinician segments as NxStage.
• Quanta Dialysis Technologies: Quanta's SC+ hemodialysis system is a compact, portable home HD device competing head-to-head with NxStage's System One and VersiHD in the home dialysis segment across the US and UK markets.

Broad incumbents

• Fresenius Medical Care: Fresenius is the global dialysis services and products leader, with its own home HD portfolio (including the 2008T and 5008X CAREsystem) and is also NxStage's distribution partner; it is a broad incumbent whose portfolio overlaps with NxStage's products.
• Baxter International: Baxter expanded its renal care portfolio by acquiring Carlyle Group's Vantive renal care business for $3.8B in August 2024, positioning itself as a broad incumbent in dialysis equipment, PD solutions, and adjacent renal therapies that compete with NxStage.
• DaVita: DaVita is one of the largest US dialysis services operators and runs a home dialysis program, making it both a major customer/influencer and a broad incumbent whose integrated kidney care strategy overlaps with NxStage's home HD focus.
• B. Braun: B. Braun's Avitum division manufactures hemodialysis machines (Dialog+, Omni) and operates dialysis centers in Europe, making it a broad incumbent in the same renal medical device category as NxStage.
• Asahi Kasei Medical: Asahi Kasei Medical is a major manufacturer of dialyzers and hemodialysis system components in Japan, supplying many dialysis equipment OEMs and competing with NxStage in adjacent renal device categories.
• Toray Medical: Toray's Medical Division produces hemodialysis machines, dialyzers, and CRRT equipment, and is a broad incumbent in the global dialysis equipment market with overlapping customer base to NxStage.

Regional players

• U.S. Renal Care: U.S. Renal Care is the third-largest US dialysis services provider with a sizable home dialysis program; while it is also a customer of NxStage products, it is a regional services player whose home HD offering competes for the same patient and physician segment.

Emerging players

• Rockwell Medical: Rockwell Medical supplies hemodialysis concentrates and is expanding into broader renal care adjacencies, making it an emerging player whose products and services intersect with NxStage's home dialysis ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/nxstage
• YouTubeyoutube.com/@NxStageMedical/videos
• Facebookfacebook.com/NxStage
• LinkedInlinkedin.com/company/nxstage-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NxStage Medical